We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Kalimantacin Polyketide Antibiotics Inhibit Fatty Acid Biosynthesis in Staphylococcus aureus by Targeting the Enoyl‐Acyl Carrier Protein Binding Site of FabI.
- Authors
Fage, Christopher D.; Lathouwers, Thomas; Vanmeert, Michiel; Gao, Ling‐Jie; Vrancken, Kristof; Lammens, Eveline‐Marie; Weir, Angus N. M.; Degroote, Ruben; Cuppens, Harry; Kosol, Simone; Simpson, Thomas J.; Crump, Matthew P.; Willis, Christine L.; Herdewijn, Piet; Lescrinier, Eveline; Lavigne, Rob; Anné, Jozef; Masschelein, Joleen
- Abstract
The enoyl‐acyl carrier protein reductase enzyme FabI is essential for fatty acid biosynthesis in Staphylococcus aureus and represents a promising target for the development of novel, urgently needed anti‐staphylococcal agents. Here, we elucidate the mode of action of the kalimantacin antibiotics, a novel class of FabI inhibitors with clinically‐relevant activity against multidrug‐resistant S. aureus. By combining X‐ray crystallography with molecular dynamics simulations, in vitro kinetic studies and chemical derivatization experiments, we characterize the interaction between the antibiotics and their target, and we demonstrate that the kalimantacins bind in a unique conformation that differs significantly from the binding mode of other known FabI inhibitors. We also investigate mechanisms of acquired resistance in S. aureus and identify key residues in FabI that stabilize the binding of the antibiotics. Our findings provide intriguing insights into the mode of action of a novel class of FabI inhibitors that will inspire future anti‐staphylococcal drug development.
- Subjects
CARRIER proteins; BINDING sites; BIOSYNTHESIS; ANTIBIOTICS; ESSENTIAL fatty acids; POLYKETIDE synthases; MUPIROCIN
- Publication
Angewandte Chemie, 2020, Vol 132, Issue 26, p10636
- ISSN
0044-8249
- Publication type
Academic Journal
- DOI
10.1002/ange.201915407